UK-BASED SUPPLIER · ESTABLISHED 2023
Research-grade peptides, verified by third-party analysis.
Supplied to independent researchers, academic laboratories, and accredited institutions. Purity verified by HPLC and mass spectrometry on every batch.
≥98%
HPLC PURITY
2pm
DISPATCH CUT-OFF
-20°C
COLD CHAIN
COA
PER BATCH
Most studied compounds
Latest from the peptide industry
Reputational Risks
MHRA Turns Its Attention to UK Peptide Clinics: What the April 2026 Investigation Means for Legitimate Research Labs
The MHRA has opened investigations into UK clinics making therapeutic claims about unregulated peptide products, following a Guardian exposé and an earlier Criminal Enforcement Unit raid in Lincolnshire. For research-procurement professionals, the enforcement shift clarifies where regulatory tolerance ends — and why robust research-use-only labelling and sourcing discipline matter more than ever.
02 Jun 2026
Pharma & GLP-1
Regeneron's $2.3 Billion Bet on Helicon Peptides: What the Parabilis Deal Signals for the Peptide Research Landscape
Regeneron Pharmaceuticals announced a research collaboration with Parabilis Medicines on 18 May 2026, valued at up to $2.32 billion, centred on Helicons — stabilised, cell-penetrant alpha-helical peptides designed to reach intracellular targets that have long resisted conventional drug design. The deal crystallises a strategic shift in how institutional capital now views structurally engineered peptides, with implications extending well beyond oncology.
01 Jun 2026
Pharma & GLP-1
Orforglipron's ATTAIN-MAINTAIN Data Clarifies the Sequential GLP-1 Strategy — and Redraws Research Priorities for Peptide Labs
The ATTAIN-MAINTAIN trial, published in Nature Medicine on 12 May 2026, shows that switching from injectable GLP-1s to oral orforglipron (Foundayo) preserved roughly 75–80% of prior weight loss over 52 weeks. For research-procurement teams, the data crystallises a new sequential treatment paradigm — and raises pointed questions about which peptide and non-peptide reference compounds will be in demand next.
01 Jun 2026
Every batch, documented.
HPLC purity analysis, mass spectrometry confirmation, and batch traceability — downloadable per product, matched to the batch code on your vial.
View our methodology →
Cold chain maintained.
Lyophilised product held at -20°C in temperature-controlled storage from receipt to dispatch. Stability guaranteed under documented conditions.
Storage protocols →
Same-day, plain packaging.
Orders placed before 2pm dispatched the same working day. Tracked UK delivery, discreet unbranded packaging as standard.
Shipping & returns →